{
  "id": 14282001,
  "title": "Bootleg Retatrutide Deaths? PMOS and Dementia; Weight-Loss Drug to Be Discontinued",
  "url": "https://urgent.news/2026/10/13/bootleg-retatrutide-deaths-pmos-and-dementia-weight-loss-drug-to-be",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-13T19:05:09.000Z",
  "source": {
    "name": "MedPage Today",
    "slug": "medpage-today",
    "url": "https://www.medpagetoday.com/endocrinology/generalendocrinology/123389"
  },
  "original_language": "en",
  "account": null,
  "summary": "(MedPage Today) -- Two recent deaths tied to counterfeit versions of retatrutide, an investigational weight-loss medication, were reported to the FDA. (CBS News) Meanwhile, ongoing lawsuits allege that GLP-1 receptor agonists can cause severe...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}